Syngene International Ltd. · NSE:SYNGENE
Syngene International — Fact Sheet (September 2024)
2 slides from Syngene International's fact sheet, September 2024
Slide 1: Syngene Biologics Fact Sheet: Putting Science to Work
Syngene Putting Science to Work Syngene's Biologics services offer a comprehensive range of solutions across drug development and manufacturing. The — expertise includes early-stage research in gene engineering and_ protein sciences, and support for diverse biological products such as antibodies and
Slide 2: Clinical and manufacturing expertise across platforms and capacity
Syngene's clinical and manufacturing expertise spans mammalian, stem cell, bacterial, yeast, and non-sporulating fungi platforms. Upstream optimization boosts titers and reduces impurities. Pichia pastoris enables non-GMP novel protein production, while the C1 platform in fungi produces monoclonal a